Compare Arista Networks Inc (ANET) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arista Networks Inc vs BridgeBio Pharma Inc — how do they compare? Arista Networks Inc trades at $202.99 (market cap $249.53B), while BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B). The key difference: Arista Networks Inc is far larger — about 15.3× BridgeBio Pharma Inc's market cap, and Arista Networks Inc is trading nearer its 52-week high, BridgeBio Pharma Inc nearer its low. Which is the better fit depends on your goals.
| ANET | BBIO | |
|---|---|---|
Market Cap | $249.53B | $16.36B |
Sector | Technology | Health |
52-Week High | $197.85 | $90.17 |
52-Week Low | $116.13 | $47.29 |
Enterprise Value | $236.19B | $18.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arista Networks Inc
Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
